Identification of Distinct Plasma Biomarker Signatures in Patients with Rapid and Slow Declining Forms of COPD
- 9 March 2010
- journal article
- research article
- Published by Taylor & Francis Ltd in COPD: Journal of Chronic Obstructive Pulmonary Disease
- Vol. 7 (1), 51-58
- https://doi.org/10.3109/15412550903499530
Abstract
Chronic obstructive pulmonary disease (COPD) is a prevalent pulmonary disease characterized by a progressive decline in lung function. The identification of biomarkers capable of predicting the rate of lung function decline or capable of giving an early read on drug efficacy in clinical trials would be very useful. The aim of this study was to identify plasma biomarkers capable of accurately distinguishing patients with COPD from healthy controls. Eighty-nine plasma markers in 40 COPD patients and 20 healthy smoker controls were analyzed. The COPD patients were divided into two subgroups, rapid and slow decliners based on their rate of lung function decline measured over 15 years. Univariate analysis revealed that 25 plasma markers were statistically different between rapid decliners and controls, 4 markers were different between slow decliners and controls, and 10 markers were different between rapid and slow decliners (p < 0.05). Multivariate analysis led to the identification of groups of plasma markers capable of distinguishing rapid decliners from controls (signature 1), slow decliners from controls (signature 2) and rapid from slow decliners (signature 3) with over 90%% classification accuracy. Importantly, signature 1 was shown to be longitudinally stable using plasma samples taken a year later from a subset of patients. This study describes a novel set of plasma markers differentiating slow from rapid decline of lung function in COPD. If validated in distinct and larger cohorts, the signatures identified will have important implications in both disease diagnosis, as well as the clinical evaluation of new therapies.Keywords
This publication has 23 references indexed in Scilit:
- Profiling serum biomarkers in patients with COPD: associations with clinical parametersThorax, 2007
- IgA antibodies to beta2-glycoprotein I and atherosclerosisAutoimmunity Reviews, 2006
- Intracellular cytokine profile of T lymphocytes in patients with chronic obstructive pulmonary diseaseClinical and Experimental Immunology, 2006
- A Review of Alpha-1 Antitrypsin DeficiencySeminars in Respiratory and Critical Care Medicine, 2005
- Local and Systemic Inflammation in Chronic Obstructive Pulmonary DiseaseProceedings of the American Thoracic Society, 2005
- Mediators of Chronic Obstructive Pulmonary DiseasePharmacological Reviews, 2004
- Increased plasma levels of soluble CD40, together with the decrease of TGFβ1, as possible differential markers of Alzheimer diseaseExperimental Gerontology, 2004
- Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysisThorax, 2004
- On the Adaptive Control of the False Discovery Rate in Multiple Testing With Independent StatisticsJournal of Educational and Behavioral Statistics, 2000
- VCAM-1/α4-integrin adhesion pathway: Therapeutic target for allergic inflammatory disordersJournal of Allergy and Clinical Immunology, 1996